Modern eCOA/ePRO and engagement platform
See how uMotif’s eCOA/ePRO platform drives unparalleled levels of patient engagement to transform the speed, quality, and accuracy of data capture.
Designed in collaboration with patients, sites and sponsors to meet the needs of all stakeholders.
uMotif’s modern eCOA/ePRO platform supports all aspects of clinical and real-world research.
Our deep understanding of how to effectively engage patients helps alleviate the burden of trial participation achieving >90% compliance in real-world studies and reducing study timelines by up to 30%.
Our patient-first approach powers studies of all sizes, from a large-scale virtual study with over 13,000 participants to a pediatric rare disease trial with just 60 critical families.
eCOA/ePRO perspectives
Insights from our patient engagement experts
-
Helping to expand our understanding of hypoglycaemic events
Explore uMotif’s role in the groundbreaking Hypo-METRICS study, which investigated the impact of hypoglycemia on the lives of patients.
Read blog -
Case study: 100 for Parkinson’s – How the uMotif platform is contributing to future research
See how uMotif’s eCOA/ePRO platform powered a global decentralized study helping Parkinson’s patients better understand their symptoms — creating a strong data foundation for future research.
Read case study -
Hear how uMotif’s eCOA/ePRO app supports patient engagement
Listen to Cathy’s story, and learn how using the uMotif eCOA/ePRO app not only enabled her to take part in this study but is having a positive impact on the management of her condition.
Watch video
High Compliance
Over 90% compliance in real-world studies
Faster Studies
Reducing study timelines by ⅓
Quality Data
Capturing GCP-compliant data, ready for submission
Get in touch to find out how we can work with you
“We needed an easy-to-use solution, that can be used across multiple countries, to manage a high volume of data capture – uMotif’s platform provides the opportunity to engage our patients”
Professor Pratik Choudhary Project Lead, King’s College London